×
About 250,406 results

ALLMedicine™ Type 2 Diabetes Center

Research & Reviews  114,203 results

Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without...
https://doi.org/10.1002/oby.23093
Obesity (Silver Spring, Md.); Katsogiannos P, Kamble PG et. al.

Feb 24th, 2021 - This study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months after Roux-en-Y gastric bypass (RYGB) with healthy controls. A total of 34 patients (21 with T2D) wi...

Time course of changes in V̇O2peak and O2 extraction during ramp cycle exercise followi...
https://doi.org/10.1152/ajpregu.00318.2020
American Journal of Physiology. Regulatory, Integrative A... Gildea N, McDermott A et. al.

Feb 24th, 2021 - In the present study we assessed the time course of adaptations in peak oxygen uptake (V̇O2peak) and muscle fractional oxygen (O2) extraction (using near-infrared spectroscopy) following 12 weeks of low-volume high-intensity interval training (HII...

Are our diabetic patients' adherent to the treatment?
https://doi.org/10.2174/1573399817666210223114010
Current Diabetes Reviews; Kumar A, Hejmady DI et. al.

Feb 24th, 2021 - To estimate the adherence to treatment among type 2 diabetic patients. Treatment adherence is a complex process which is controlled by multiple factors. Lack of treatment adherence is common with patients who suffer from type 2 diabetes and is bec...

DNA methylation of blood cells is associated with prevalent type 2 diabetes in a meta-a...
https://doi.org/10.1186/s13148-021-01027-3 10.1007/s00125-015-3773-7 10.1093/hmg/ddv232 10.1016/S0140-6736(11)60614-4 10.1210/er.2015-1137 10.1007/s00592-015-0741-0 10.2337/diacare.21.3.C3 10.2337/db16-1253 10.1038/s41588-018-0241-6 10.1038/nrg3000 10.1038/nrg3405 10.1007/978-94-007-2495-2 10.1093/hmg/ddv493 10.3389/fendo.2018.00744 10.1186/s13059-016-0926-z 10.1186/1471-2164-15-860 10.1038/s41467-019-12228-z 10.1080/15592294.2016.1178418 10.1016/j.molmet.2018.01.022 10.1186/s13148-016-0177-6 10.1016/S2213-8587(15)00127-8 10.2337/db18-0290 10.1093/ije/dyy171 10.1007/s00125-017-4497-7 10.1093/bioinformatics/btv560 10.1093/bioinformatics/btv612 10.1038/ng.3721 10.1038/ng.521 10.1038/ng.520 10.1093/hmg/ddv161 10.2337/db13-1100 10.1161/CIRCGENETICS.114.000804 10.1371/journal.pone.0152314 10.2337/dc19-1828 10.2337/dc12-0082 10.1038/nature20784 10.1161/CIRCULATIONAHA.114.009158 10.1093/hmg/ddt430 10.1194/jlr.M048504 10.1016/j.numecd.2016.11.004 10.1371/journal.pone.0145789 10.1161/ATVBAHA.117.310340 10.1016/j.celrep.2018.05.035 10.3389/fphar.2018.00207 10.1161/CIRCGENETICS.116.001506 10.1080/15592294.2016.1278097 10.1016/B978-0-12-814259-2.00012-1 10.1093/ije/dyz119 10.2337/db15-0996 10.1093/hmg/ddx164 10.1093/ije/dys066 10.1093/ije/dys064 10.1186/1471-2318-7-28 10.1093/ije/dyr197 10.1093/ije/dyy022 10.1007/s10654-017-0321-4 10.1007/s10654-020-00640-5 10.1055/s-2005-858235 10.1186/1471-2105-13-86 10.1093/bioinformatics/bts034 10.1080/01621459.1986.10478363 10.1186/s13148-017-0414-7 10.1186/s13073-020-0716-9 10.3390/nu11112804 10.1093/bioinformatics/bty362 10.1093/bioinformatics/btq340 10.18637/jss.v036.i03 10.1093/bioinformatics/bts545 10.1186/1756-8935-6-26 10.1038/ng.2897 10.2337/db10-0502
Clinical Epigenetics; Juvinao-Quintero DL, Marioni RE et. al.

Feb 24th, 2021 - Type 2 diabetes (T2D) is a heterogeneous disease with well-known genetic and environmental risk factors contributing to its prevalence. Epigenetic mechanisms related to changes in DNA methylation (DNAm), may also contribute to T2D risk, but larger...

see more →

Guidelines  401 results

Drug activates brown fat, improves glucose metabolism in healthy women
https://www.nih.gov/news-events/nih-research-matters/drug-activates-brown-fat-improves-glucose-metabolism-healthy-women
National Institutes of Health (NIH)

Feb 3rd, 2021 - The majority of adults in the U.S. carry too much fat in their bodies and are now considered overweight or obese. The last several decades have also seen a spike in related diseases of metabolism, such as type 2 diabetes.

Brown fat associated with less heart and metabolic disease
https://www.nih.gov/news-events/nih-research-matters/brown-fat-associated-less-heart-metabolic-disease
National Institutes of Health (NIH)

Feb 1st, 2021 - Too much white fat, a characteristic of obesity, has been shown to increase the risk of type 2 diabetes, high blood pressure, and other diseases. A less common type of fat, called brown fat, uses blood sugar and fat molecules to create heat and he...

Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785422/
Obesity Medicine; Pang J, Liu M et. al.

Jan 5th, 2021 - COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 di...

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Comparative Performances of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes
https://www.rheumatologyadvisor.com/home/conference-highlights/acr-convergence-2020/comparative-performance-of-sglt2-inhibitors-in-reducing-gout-in-t2d/

Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...

see more →

Drugs  2,543 results see all →

Clinicaltrials.gov  123,621 results

Glimepiride - glimepiride tablet-Solco Healthcare U.S., LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without...
https://doi.org/10.1002/oby.23093
Obesity (Silver Spring, Md.); Katsogiannos P, Kamble PG et. al.

Feb 24th, 2021 - This study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months after Roux-en-Y gastric bypass (RYGB) with healthy controls. A total of 34 patients (21 with T2D) wi...

Time course of changes in V̇O2peak and O2 extraction during ramp cycle exercise followi...
https://doi.org/10.1152/ajpregu.00318.2020
American Journal of Physiology. Regulatory, Integrative A... Gildea N, McDermott A et. al.

Feb 24th, 2021 - In the present study we assessed the time course of adaptations in peak oxygen uptake (V̇O2peak) and muscle fractional oxygen (O2) extraction (using near-infrared spectroscopy) following 12 weeks of low-volume high-intensity interval training (HII...

Are our diabetic patients' adherent to the treatment?
https://doi.org/10.2174/1573399817666210223114010
Current Diabetes Reviews; Kumar A, Hejmady DI et. al.

Feb 24th, 2021 - To estimate the adherence to treatment among type 2 diabetic patients. Treatment adherence is a complex process which is controlled by multiple factors. Lack of treatment adherence is common with patients who suffer from type 2 diabetes and is bec...

see more →

News  9,559 results

Goldenseal May Interfere With Metformin, Jeopardize Glucose Control
https://www.medscape.com/viewarticle/946380

Feb 23rd, 2021 - Goldenseal, a natural botanical product, may interfere with intestinal absorption of metformin, potentially compromising blood glucose control in patients with type 2 diabetes, according to investigators. The study, which tested for interactions b...

Type 2 Diabetes Linked to Impaired Pulmonary Function
https://www.medscape.com/viewarticle/946279

Feb 22nd, 2021 - Takeaway Type 2 diabetes (T2D) is associated with pulmonary function impairment, independent of sex, smoking status, or worldwide location.

Is Type 2 Diabetes Linked to Increased Risk of Rheumatoid Arthritis?
https://www.medscape.com/viewarticle/946022

Feb 18th, 2021 - Takeaway This study found a reduced risk of rheumatoid arthritis (RA) that was potentially attributable to the use of statin in patients with type 2 diabetes (T2D).

Aged 40+ With Diabetes Hit Badly by COVID-19, Should Be Vaccine Priority
https://www.medscape.com/viewarticle/945829

Feb 14th, 2021 - People with type 2 diabetes as young as 40 years of age face a disproportionately increased risk of dying from COVID-19 infection, indicates a UK analysis of three large-scale datasets that shines a light on the need to prioritize vaccinations in ...

Wide Swings in Blood Glucose Linked to More CVD in Diabetes
https://www.medscape.com/viewarticle/945645

Feb 10th, 2021 - Patients with type 2 diabetes and the highest level of variability in their A1c levels over 2 years had significantly more first cardiovascular disease (CVD) events than similar patients with less A1c variability, in a retrospective analysis of mo...

see more →

Patient Education  79 results see all →